Strides Pharma Science Limited (NSE:STAR)

Strides Pharma Science Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	-	1,610	3,035	1,707	1,258	1,822
Short-Term Investments	-	227.8	63.63	134.55	1,490	1,652
Trading Asset Securities	-	1,058	508.4	-	-	-
Cash & Short-Term Investments	2,470	2,896	3,607	1,842	2,749	3,474
Cash Growth	-24.31%	-19.72%	95.84%	-32.99%	-20.88%	-56.13%
Accounts Receivable	-	11,419	12,994	12,073	11,106	9,317
Other Receivables	-	1,462	936.49	5,899	367.53	320.52
Receivables	-	13,008	14,008	18,020	11,514	9,786
Inventory	-	11,262	11,465	11,738	12,007	7,825
Prepaid Expenses	-	706.94	639.29	541.85	526.86	484.2
Other Current Assets	-	1,817	2,714	1,476	1,376	2,152
Total Current Assets	-	29,690	32,434	33,618	28,172	23,721
Property, Plant & Equipment	-	9,585	13,726	15,136	14,994	14,639
Long-Term Investments	-	2,015	4,422	5,416	6,120	4,336
Goodwill	-	5,294	5,138	4,859	4,805	4,286
Other Intangible Assets	-	5,271	5,631	6,250	6,185	5,463
Long-Term Deferred Tax Assets	-	2,673	2,650	2,151	1,982	1,986
Other Long-Term Assets	-	3,368	2,385	2,297	7,787	6,697
Total Assets	-	58,398	66,384	69,759	70,150	61,517
Accounts Payable	-	8,516	9,823	10,715	11,342	7,977
Accrued Expenses	-	1,229	1,287	1,348	1,318	713.73
Short-Term Debt	-	15,742	13,308	14,965	10,238	12,288
Current Portion of Long-Term Debt	-	1,689	3,039	4,598	1,970	1,291
Current Portion of Leases	-	307.05	514.39	465.98	345.7	190.92
Current Income Taxes Payable	-	404.16	267.11	238.11	351.18	383.2
Current Unearned Revenue	-	-	-	-	-	72.17
Other Current Liabilities	-	905.91	1,664	1,786	1,819	2,533
Total Current Liabilities	-	28,793	29,902	34,117	27,383	25,449
Long-Term Debt	-	6,715	11,398	8,356	8,826	6,039
Long-Term Leases	-	716.35	2,037	1,865	2,103	2,538
Long-Term Unearned Revenue	-	-	-	-	1.08	3.38
Long-Term Deferred Tax Liabilities	-	403.45	445.71	357.19	463.48	208.16
Other Long-Term Liabilities	-	504.78	464.61	780.18	2,829	1,018
Total Liabilities	-	37,680	44,655	45,925	42,010	35,571
Common Stock	-	919	903.03	897.9	896.81	895.65
Additional Paid-In Capital	-	18,233	17,545	17,322	17,273	17,008
Retained Earnings	-	1,197	2,037	4,060	8,865	6,355
Comprehensive Income & Other	-	906.9	1,638	1,312	731.94	1,016
Total Common Equity	22,714	21,256	22,123	23,592	27,767	25,274
Minority Interest	-	-538.57	-393.75	240.88	373.41	672.38
Shareholders' Equity	22,150	20,717	21,729	23,833	28,140	25,947
Total Liabilities & Equity	-	58,398	66,384	69,759	70,150	61,517
Total Debt	23,085	25,169	30,296	30,250	23,482	22,347
Net Cash (Debt)	-20,615	-22,273	-26,689	-28,408	-20,734	-18,872
Net Cash Per Share	-224.17	-244.75	-296.27	-316.54	-231.12	-210.67
Filing Date Shares Outstanding	91.99	91.9	90.3	89.8	89.68	89.57
Total Common Shares Outstanding	91.99	91.9	90.3	89.79	89.68	89.57
Working Capital	-	897.4	2,532	-498.44	788.86	-1,727
Book Value Per Share	247.04	231.29	244.98	262.75	309.62	282.19
Tangible Book Value	11,403	10,690	11,354	12,483	16,776	15,526
Tangible Book Value Per Share	124.01	116.33	125.73	139.03	187.06	173.34
Land	-	1,416	1,410	1,383	1,041	1,040
Buildings	-	3,225	3,844	4,205	2,857	2,868
Machinery	-	9,048	12,539	13,042	11,264	10,192
Construction In Progress	-	798.79	482.59	562.29	2,276	1,481

Source: S&P Capital IQ. Standard template. Financial Sources.